{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-015161","form_type":"8-K","ticker":"TENX","cik":"0000034956","company_name":"TENAX THERAPEUTICS, INC.","filed_at":"2024-12-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.712333+00:00","generated_at":"2026-05-29T09:07:20.759492+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Tenax Therapeutics appoints Thomas A. McGauley as Interim CFO, effective Dec 2, 2024","bullets":["Thomas A. McGauley appointed Interim CFO and principal financial/accounting officer, replacing Lawrence R. Hoffman.","McGauley provides services through Danforth Advisors at $410 per hour with up to 4% annual increase.","McGauley has 25+ years financial experience, including interim CFO at Galectin Therapeutics and manager at PwC.","He holds a CPA and B.S.B.A in Accounting from Stonehill College; no familial relationships with officers or directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-015161","json":"https://secwatch.observer/filing/0001654954-24-015161.json","markdown":"https://secwatch.observer/filing/0001654954-24-015161.md","text":"https://secwatch.observer/filing/0001654954-24-015161.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/34956/000165495424015161/0001654954-24-015161-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/34956/000165495424015161/tenx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T09:07:20.759492+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}